Your browser is no longer supported. Please, upgrade your browser.
ATXI Avenue Therapeutics, Inc. daily Stock Chart
Avenue Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.58 Insider Own1.60% Shs Outstand16.52M Perf Week-2.37%
Market Cap55.14M Forward P/E- EPS next Y-0.30 Insider Trans-1.41% Shs Float6.65M Perf Month-4.91%
Income-9.60M PEG- EPS next Q-0.06 Inst Own17.00% Short Float4.52% Perf Quarter-70.88%
Sales- P/S- EPS this Y21.70% Inst Trans4.63% Short Ratio1.07 Perf Half Y-69.68%
Book/sh0.20 P/B16.45 EPS next Y3.20% ROA-151.40% Target Price- Perf Year-45.17%
Cash/sh- P/C- EPS next 5Y- ROE-192.30% 52W Range2.85 - 12.34 Perf YTD-65.73%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-73.34% Beta0.52
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin- 52W Low15.44% ATR0.18
Employees4 Current Ratio3.90 Sales Q/Q- Oper. Margin- RSI (14)25.22 Volatility3.88% 6.33%
OptionableNo Debt/Eq0.00 EPS Q/Q54.50% Profit Margin- Rel Volume0.54 Prev Close3.36
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume280.06K Price3.29
Recom2.00 SMA203.46% SMA50-49.25% SMA200-63.65% Volume153,130 Change-2.08%
Nov-13-20 05:28AM  
Oct-28-20 07:45PM  
Oct-23-20 10:00PM  
Oct-14-20 08:58PM  
Oct-13-20 01:29PM  
Oct-12-20 01:35PM  
Sep-09-20 08:00AM  
Aug-17-20 10:33AM  
Aug-14-20 07:30AM  
Aug-04-20 12:53PM  
Jul-28-20 05:50PM  
Jul-22-20 05:50PM  
Jul-21-20 08:30AM  
Jul-16-20 05:50PM  
Jul-09-20 05:50PM  
Jul-07-20 11:50AM  
Jun-29-20 08:30AM  
Jun-25-20 08:44AM  
Jun-24-20 12:00PM  
Jun-23-20 10:38AM  
Jun-18-20 10:12AM  
Jun-17-20 11:30AM  
Jun-16-20 08:37AM  
Jun-15-20 10:00AM  
Jun-11-20 08:55AM  
Jun-10-20 08:31AM  
Jun-09-20 09:41AM  
Jun-08-20 08:25AM  
Jun-05-20 08:30AM  
May-29-20 11:33AM  
May-28-20 09:13AM  
May-27-20 12:43PM  
May-26-20 10:44AM  
May-22-20 08:42AM  
May-11-20 07:30AM  
Apr-27-20 09:48AM  
Apr-24-20 11:07AM  
Apr-23-20 09:14AM  
Apr-16-20 12:00PM  
Mar-30-20 07:30AM  
Feb-13-20 08:00AM  
Dec-13-19 08:10AM  
Dec-11-19 08:30AM  
Nov-04-19 07:30AM  
Oct-28-19 08:30AM  
Oct-18-19 08:30AM  
Aug-14-19 07:30AM  
Aug-01-19 08:00AM  
Jun-07-19 01:51PM  
Jun-03-19 12:05PM  
May-13-19 07:30AM  
Apr-30-19 07:30AM  
Mar-12-19 07:30AM  
Feb-11-19 07:30AM  
Jan-28-19 10:05AM  
Jan-19-19 06:45PM  
Dec-19-18 08:00AM  
Dec-12-18 08:00PM  
Dec-03-18 09:15AM  
Nov-21-18 07:45AM  
Nov-14-18 04:30PM  
Nov-13-18 12:00PM  
Aug-27-18 01:45PM  
Aug-14-18 07:30AM  
Aug-02-18 10:29AM  
Jun-19-18 08:30AM  
Jun-12-18 09:30AM  
Jun-06-18 08:30AM  
May-23-18 07:25AM  
May-21-18 08:59AM  
May-14-18 10:30AM  
May-03-18 07:30AM  
Apr-10-18 01:20PM  
Mar-28-18 08:00AM  
Mar-05-18 08:00AM  
Mar-01-18 07:30AM  
Feb-09-18 10:00AM  
Feb-06-18 08:30AM  
Jan-02-18 08:00AM  
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was founded in 2015 and is based in New York, New York. Effective as of December 31, 2019, Avenue Therapeutics, Inc. operates as a subsidiary of InvaGen Pharmaceuticals, Inc.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vazzano Joseph WalterChief Financial OfficerAug 20Sale12.133,84046,57957,412Aug 21 04:15 PM
Vazzano Joseph WalterChief Financial OfficerMar 10Buy7.941,88914,99961,252Mar 10 04:42 PM
Vazzano Joseph WalterChief Financial OfficerMar 09Buy7.991,50011,98359,363Mar 10 04:42 PM
Herskowitz NeilDirectorFeb 27Buy8.202,40019,680122,224Mar 02 08:10 AM
Herskowitz NeilDirectorFeb 26Buy8.731611,406119,824Mar 02 08:10 AM
Vazzano Joseph WalterChief Financial OfficerFeb 25Buy9.091,20010,90857,863Feb 25 04:55 PM
Herskowitz NeilDirectorFeb 25Buy9.3110,00093,100119,663Feb 25 04:53 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.